|
|
Volumn 8, Issue 2, 2007, Pages 121-
|
|
Etanercept for the management of oral lichen planus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
ETANERCEPT;
PREDNISONE;
RETINOID;
TACROLIMUS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ADULT;
CASE REPORT;
CAUCASIAN;
CORTICOSTEROID THERAPY;
DIABETES MELLITUS;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
EROSION;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HYPERTENSION;
IMMUNOFLUORESCENCE;
INJECTION SITE PAIN;
KERATINIZATION;
LETTER;
LICHEN PLANUS;
MOUTH DISEASE;
MOUTH MUCOSA;
MOUTH ULCER;
PRIORITY JOURNAL;
SYSTEMIC THERAPY;
TOPICAL TREATMENT;
MIDDLE AGED;
SUBCUTANEOUS DRUG ADMINISTRATION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS, SUBCUTANEOUS;
LICHEN PLANUS, ORAL;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
|
EID: 34250677788
PISSN: 11750561
EISSN: None
Source Type: Journal
DOI: 10.2165/00128071-200708020-00010 Document Type: Letter |
|
Times cited : (44)
|
|
References (5)
|
